Survey Study on Barrett's Esophagus Screening
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora, Dallas, and Philadelphia, United StatesSee the 7 sites
- Trial code
- Status
- Completed
- People taking part
- 725 people enrolled
- Started
- 19 Feb 2020
- Ended
- 1 Oct 2025
- Type of study
- Observational, 3 groups
- Treatments tested
- Primary Care Provider Survey
- Gastroenterologist Survey
- Patient Survey
- Record updated
- 22 October 2025
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients identified by ICD-10 codes for GERD (K21.0 and K21.9) AND
- Have had at least one outpatient clinic visit at a participating site
- Provider must be a PCP and/or gastroenterologist AND
- Must be at a participating site
Who cannot take part
- Prior diagnosis of BE/EAC
- Non-English speaking
- Provider Eligibility Criteria
Other criteria
- Patient Eligibility Criteria
Where in United States
- Denver Health Medical CenterAurora, United States
- University of Colorado HospitalAurora, United States
- Parkland Health and Hospital SystemDallas, United States
- University of Texas Southwestern Medical CenterDallas, United States
- Hospital of the University of PennsylvaniaPhiladelphia, United States
- Pennsylvania HospitalPhiladelphia, United States
- Pennsylvania Presbyterian HospitalPhiladelphia, United States
About the trial
What the trial wants to find out
The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal Adenocarcinoma (EAC).
The 3 groups in the trial
- Primary Care Providers
400 eligible primary care providers (PCPs) will be recruited across the 7 participating sites to complete an anonymous survey. The survey will be distributed to eligible PCPs by the study site research coordinator via anonymous REDCap internet survey with 2 additional automated electronic reminders. There will also be opportunities for providers to complete a paper survey at PCP clinic meetings which will be collected by only the site research coordinator to maintain response anonymity.
Treatment: Primary Care Provider Survey
- Gastroenterologists
100 eligible gastroenterologists (GIs) will be recruited across the 7 participating sites to complete an anonymous survey. The survey will be distributed to eligible GIs by the study site research coordinator via anonymous REDCap internet survey with 2 additional automated electronic reminders. There will also be opportunities for GIs to complete a paper survey at provider clinic meetings which will be collected by only the site research coordinator to maintain response anonymity.
Treatment: Gastroenterologist Survey
- Patients
500 eligible patients will be recruited across the 7 participating sites to complete a survey. The survey will be distributed to eligible patients at the time of a clinic appointment, via telephone, or via a REDCap internet survey that will allow for 2 additional electronic phone call reminders and 1 email reminder.
Treatment: Patient Survey
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study of Compliance, Practice Patterns, and Barriers REgarding Established National Screening Programs for Barrett's Esophagus: SCREEN-BE
- Publications
- Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening.The American journal of gastroenterology, 2023
- Record updated
- 22 October 2025